MiNK Therapeutics, Inc. Common Stock
INKT
Closed
$11.04
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in New York City, New York and currently employs 15 full-time employees. The company went IPO on 2021-10-15.
Country
US
CEO
Dr. Jennifer Buell
IPO date
2021
Employees
15
ISIN
US6036932019
Website
Key stats
Open
$11.45
Volume
36.03K
Market cap
$57.09M
Prev. close
$11.46
Impl / hst vl
-
Open interest
$0.00
$11.04
Day’s Range
$11.55
$8.48
52W Range
$16.93
Valuation
11
Valuation score
Strongly Overvalued
P/E
-
P/S
-
P/B
-
Current ratio
1.38
Debt / Equity
-
ROE
-
Gross margin
-
Income growth
5.39%
FCF growth
-16.45
Analysts estimates
Consensus rating
Buy
The average rating from top 5 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$39.78
The top 4 analysts forecasts that 12-month price may increase by 260.33%, with a low of $35.35 and a high of $45.15
$35.35
Low
$39.78
Avg
$45.15
High
Current price
Earnings
Q1 ‘26 revenue
$0.00
Q1 ‘26 net income
-$2.74M
Revenue
Net income
Previous EPS
-$0.57
Estimate EPS
-$0.61
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply